Join
Live feed
·
PRReleasevia Quantisnow
Lixte Biotechnology Holdings Inc. logo

LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100

ByQuantisnow·Wall Street's wire, on your screen.
LIXT· Lixte Biotechnology Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIXT (Lixte Biotechnology Holdings Inc.) and more on Quantisnow.